Lonza Group AG
LONN.SW$43.13B
Large CapSIXBiotechnology🇨🇭Europe20.1K employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LONN.SW News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
No drugs found in this phase.
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Lonza Group AG's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Lonza Group AG (LONN.SW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LONN.SW biotech catalysts?→
Add LONN.SW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lonza Group AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply